While abnormalities of voice were already present in patients with only mild overall motor impairment, additional deterioration of articulation and fluency appeared in the more advanced stages of the disease. On the other hand, subtle telemetric analyses of Sarafloxacin HCl different speech variables have been successfully used to predict the severity of PD in a pilot study on a large number of 82 patients. However, according to the present data, worsening of speech performance seem to follow an individual pace without clear correlation to progression of motor performance or disease duration, since there were no correlations between changes of tVSA or VAI and the time period passed between the visits. Summarized, the current study together with the afore mentioned findings justify the assumption that acoustic analyses of vowel articulation and dysprosody could turn out to become a useful instrument for the monitoring of non-dopaminergic disease progression at least in the more advanced stages of PD, since impairment of vowel articulation was found to parallel the increasing deterioration of gait. Additional investigations are needed to clarify and further substantiate a possible differential value of tVSA and VAI measurement in the different gender and different stages of disease. Further longitudinal studies with Ganciclovir regard to several distinct speech parameters are warranted with standardized follow-up examinations to obtain further insight into pathophysiology and progression of speech impairment in Parkinson��s disease. Under normal physiological conditions, the healthy adult heart derives 60�C70% of its energy from the b-oxidation of long chain fatty acids, with the remainder predominantly from carbohydrate sources, such as glucose. Fatty acids are a more energy dense fuel, but require more oxygen for a given amount of ATP formed, when compared with glucose. Therefore, increasing glucose metabolism at the expense of fatty acid metabolism may be beneficial when oxygen is limited. In patients with cardiac hypertrophy, fatty acid utilisation is decreased and glucose utilisation is increased. This metabolic shift is proportional to the extent of cardiac hypertrophy, as fatty acid uptake and oxidation inversely correlate with left ventricular mass and end-diastolic diameter. The underlying mechanisms by which fatty acid utilisation is decreased in cardiac hypertrophy are not fully understood. Biopsies taken from patients with heart failure have reduced mRNA expression of the mitochondrial genes medium chain acyl-coenzyme A dehydrogenase, carnitine palmitoyl transferase I and citrate synthase. However, a greater understanding of how metabolic proteins in the various pathways change in relation to each other will give a greater insight into the mechanisms underpinning regulation of in vivo metabolic flux in the human heart. Sarcolemmal fatty acid transporters are the primary regulated step in cardiac fatty acid metabolism.